Package Label (PRINCIPAL DISPLAY PANEL – 600 mg (30 Tablet Bottle))
Efavirenz Tablet, Film Coated
Product Images NDC 65862-049
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Efavirenz (NDC 65862-049). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Package Label-principal Display Panel (600 mg Blister Carton (3 x 10 Unit-dose))
This is a description of Efavirenz Tablets USP which is a film-coated tablet used for the treatment of HIV infection. Each tablet contains 600 mg of efavirenz USP. The usual dosage instructions are provided in the package insert. The tablets are to be stored at 20° to 25°C (68° to 77°F). Pharmacists are advised not to cover the ALERT box with a pharmacy label. The manufacturer is Aurobindo Pharma USA, Inc. and the tablets are made in India. Information on medicines that should not be taken with Efavirenz Tablets is included.*
Chemical Structure (Efavirenz Str)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
